Profit Over Patients? A Critical Look at At-Home Ketamine Therapy

The advent of at-home ketamine therapy in mental health treatment has provided hope for many, but it also brings significant ethical concerns to the fore. My journey as the former CEO of Nue Life Health, leading a team that facilitated over 100,000 ketamine treatments, provided me with unique insights into the pitfalls of this emerging field. My position, influenced by recent FDA guidance, is firm: I can no longer endorse at-home ketamine therapy for patients. To be sure, the advent of at-home ketamine therapy represents a groundbreaking shift towards innovative treatment options. As the conversation around psychedelic medicine grows, so too does the urgency to address its ethical implications. <a href="https://medium.com/@jpc_63703/profit-over-patients-a-critical-look-at-at-home-ketamine-therapy-72986f6aab7d">Read More</a>